Lv31
318 积分 2026-02-26 加入
Characteristics of Soluble PD‐L1 and PD‐1 Expression and Their Correlations With Immune Status and Prognosis in Advanced Lung Cancer
1个月前
已完结
Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications
1个月前
已完结
An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox
1个月前
已完结
A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domains
1个月前
已完结
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer
2个月前
已完结
Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review
3个月前
已完结
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma
3个月前
已完结
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
3个月前
已完结
Target Occupancy Biomarker Assay Development Using a Conformation-Selective Antibody Against Small-Molecule-Bound TNF
4个月前
已完结
Estimation of the serum level of a proliferation-inducing ligand in patients with psoriasis and lichen planus
5个月前
已关闭
皖公网安备34019202002308
